Manufacturers Life Insurance Company, The Madrigal Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 29,957 shares of MDGL stock, worth $9.24 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
29,957
Previous 35,678
16.04%
Holding current value
$9.24 Million
Previous $10 Million
36.4%
% of portfolio
0.01%
Previous 0.01%
Shares
32 transactions
Others Institutions Holding MDGL
# of Institutions
297Shares Held
22MCall Options Held
819KPut Options Held
640K-
Janus Henderson Group PLC London, X02.48MShares$764 Million0.28% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$630 Million29.57% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$626 Million6.48% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$615 Million6.74% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$609 Million4.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.28B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...